Private equity firm Advent International said that it has acquired a controlling stake in Bharat Serums and Vaccines, which operates in women’s healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets. The deal value was not disclosed. The company currently develops, produces and markets injectable biological and pharmaceutical products for gynaecology, critical care, emergency medicine, urology, neurology and assisted reproductive technology. It has three manufacturing plants in Maharashtra and its products are registered in more than 45 countries.

(Dealstreet Asia)